Cargando…

A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models

Human immunodeficiency virus (HIV) types 1 and 2 (HIV-1 and HIV-2) are the etiologic agents of AIDS. Most HIV-1 infected individuals worldwide are women, who acquire HIV infections during sexual contact. Blocking HIV mucosal transmission and local spread in the female lower genital tract is importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyapalle, Sandhya, Xu, Weidong, Raulji, Payal, Mohapatra, Subhra, Mohapatra, Shyam S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583459/ https://www.ncbi.nlm.nih.gov/pubmed/26407080 http://dx.doi.org/10.1371/journal.pone.0135288

Ejemplares similares

Nanotechnology Applications to HIV Vaccines and Microbicides
por: Boyapalle, Sandhya, et al.
Publicado: (2012)

Respiratory Syncytial Virus NS1 Protein Colocalizes with Mitochondrial Antiviral Signaling Protein MAVS following Infection
por: Boyapalle, Sandhya, et al.
Publicado: (2012)

A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo
por: Villegas, Guillermo, et al.
Publicado: (2016)

Respiratory Syncytial Virus (RSV) Infection in Elderly Mice Results in Altered Antiviral Gene Expression and Enhanced Pathology
por: Wong, Terianne M., et al.
Publicado: (2014)

Natriuretic Peptide Receptor A as a Novel Target for Prostate Cancer
por: Wang, Xiaoqin, et al.
Publicado: (2011)

A Potent Combination Microbicide that Targets SHIV-RT, HSV-2 and HPV
por: Kizima, Larisa, et al.
Publicado: (2014)

Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery
por: Zhang, Weidong, et al.
Publicado: (2004)

In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
por: Rohan, Lisa C., et al.
Publicado: (2010)

Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
por: Khalil, Roukiah, et al.
Publicado: (2023)

MiniCD4 Microbicide Prevents HIV Infection of Human Mucosal Explants and Vaginal Transmission of SHIV(162P3) in Cynomolgus Macaques
por: Dereuddre-Bosquet, Nathalie, et al.
Publicado: (2012)

New perspectives on central and peripheral immune responses to acute traumatic brain injury
por: Das, Mahasweta, et al.
Publicado: (2012)

Dendrimers Show Promise for siRNA and microRNA Therapeutics
por: Dzmitruk, Volha, et al.
Publicado: (2018)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018)

Progress towards in Vivo Use of siRNAs
por: Behlke, Mark A.
Publicado: (2006)

Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor
por: Wang, Xiaoqin, et al.
Publicado: (2008)

Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
por: Green, Ryan, et al.
Publicado: (2022)

Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo
por: Crakes, Katti R, et al.
Publicado: (2020)

Attenuation of fibrosis in vitro and in vivo with SPARC siRNA
por: Wang, Jiu-Cun, et al.
Publicado: (2010)

Progress Toward In Vivo Use of siRNAs-II
por: Rettig, Garrett R, et al.
Publicado: (2012)

siRNA-optimized Modifications for Enhanced In Vivo Activity
por: Kenski, Denise M, et al.
Publicado: (2012)

Microbicides for HIV prevention
por: Ramjee, Gita
Publicado: (2011)

Cheminformatics Modeling of Gene Silencing for Both Natural and Chemically Modified siRNAs
por: Dong, Xialan, et al.
Publicado: (2022)

Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019)

Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route
por: Meryet-Figuière, Matthieu, et al.
Publicado: (2017)

In vivo silencing of alpha-synuclein using naked siRNA
por: Lewis, Jada, et al.
Publicado: (2008)

Non-viral siRNA delivery into the mouse retina in vivo
por: Turchinovich, Andrey, et al.
Publicado: (2010)

Novel siRNA Delivery System to Target Podocytes In Vivo
por: Hauser, Peter V., et al.
Publicado: (2010)

Tracking in vitro and in vivo siRNA electrotransfer in tumor cells
por: Paganin-Gioanni, Aurelie, et al.
Publicado: (2008)

In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes
por: Shrivats, Arun R., et al.
Publicado: (2015)

Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
por: Tai, Wanyi
Publicado: (2019)

Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017)

Structural Modifications of siRNA Improve Its Performance In Vivo
por: Chernikov, Ivan V., et al.
Publicado: (2023)

Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury
por: Willing, Alison E., et al.
Publicado: (2020)

Live microbial microbicides for HIV
por: Hamer, Dean, et al.
Publicado: (2006)

Microbicides & their implications in HIV prevention
por: Karim, Salim S. Abdool, et al.
Publicado: (2010)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

114 A Highly Sensitive and Specific Universal Mirna Profiling Method
por: Wang, Jia-Wang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_57rqsn3ijq465i0kjeta1461o6